Found: 16
Select item for more details and to access through your institution.
How frothy is this IPO window?
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 1, p. 11, doi. 10.1038/nbt0115-11
- By:
- Publication type:
- Article
Intercept price quadruples in a day.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 3, p. 207, doi. 10.1038/nbt0314-207
- By:
- Publication type:
- Article
Celgene's multibillion spree on Oncomed/NYC.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 116, doi. 10.1038/nbt0214-116a
- By:
- Publication type:
- Article
JDRF teams with VC PureTech to promote startups.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 12, p. 1065, doi. 10.1038/nbt1213-1065a
- By:
- Publication type:
- Article
GSK shares spoils with Avalon.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 7, p. 579, doi. 10.1038/nbt0713-579a
- By:
- Publication type:
- Article
San Diego survives Amylin shock.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 6, p. 475, doi. 10.1038/nbt0613-475
- By:
- Publication type:
- Article
Biotech crowdfunding paves way for angels.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 11, p. 1020, doi. 10.1038/nbt1112-1020a
- By:
- Publication type:
- Article
Merck Serono spinouts.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 10, p. 907, doi. 10.1038/nbt1012-907
- By:
- Publication type:
- Article
Amylin's $7 billion GLP-1 deal.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 8, p. 730, doi. 10.1038/nbt0812-730a
- By:
- Publication type:
- Article
Pharma incubates without strings.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 4, p. 297, doi. 10.1038/nbt0412-297b
- By:
- Publication type:
- Article
Shutdown by auction.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 12, p. 1060, doi. 10.1038/nbt1211-1060a
- By:
- Publication type:
- Article
ATM cash for biotechs.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 10, p. 856, doi. 10.1038/nbt1011-856a
- By:
- Publication type:
- Article
Gates eyes biotechs as for-profit investments.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 559, doi. 10.1038/nbt0711-559a
- By:
- Publication type:
- Article
Chinese biotechs wrestle with transparency, cultural hurdles.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 5, p. 377, doi. 10.1038/nbt0511-377
- By:
- Publication type:
- Article
Boardroom tensions rise as investors push for liquidation.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 492, doi. 10.1038/nbt0609-492
- By:
- Publication type:
- Article
Nine novel conserved motifs in BRCA1 identified by the chicken orthologue.
- Published in:
- Oncogene, 2001, v. 20, n. 32, p. 4433, doi. 10.1038/sj.onc.1204485
- By:
- Publication type:
- Article